Skip to main content

Circulating interleukin-15 and RANTES chemokine in Parkinson’s disease

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Rentzos M, Nikolaou C, Andreadou E, Paraskevas GP, Rombos A, Zoga M, Tsoutsou A, Boufidou F, Kapaki E, Vassilopoulos D. Circulating interleukin-15 and RANTES chemokine in Parkinson’s disease.

Acta Neurol Scand 2007: 116: 374–379.

© 2007 The Authors Journal compilation © 2007 Blackwell Munksgaard.

Interleukin-15 promotes T-cell proliferation, induction of cytolytic effector cells including natural killer (NK) and cytotoxic cells and stimulates B-cell to proliferate and secrete immunoglobulins. RANTES is a C-C beta chemokine with strong chemoattractant activity for T lymphocytes and monocytes. Objectives – 

The objective of our study was to find out whether IL-15 and RANTES are involved in the possible inflammatory reactions of PD. Patients and methods – 

We measured by immunoassay serum IL-15 and RANTES levels in 41 patients with PD in comparison with serum levels in 19 healthy subjects age and sex-matched. IL-15 and RANTES levels were correlated with sex, age, disease duration. H-Y stage and the UPDRS III score in all the studied groups and were also correlated with treatment status in PD patients. Results – 

The PD group presented with significantly increased RANTES levels as compared to the control group (P = 0.0009). No difference was observed as regards IL-15 levels. A strong and significant correlation between RANTES levels and UPDRS III score was observed in PD patients (Rs = 0.42, P = 0.007). Untreated patients had significantly higher RANTES levels as compared to the controls. Conclusions – 

Our findings may suggest a recruitment of activated monocytes, macrophages and T lymphocytes to sites of inflammation in the central nervous system of PD patients.

Keywords: Elisa; IL-15; L-dopa treatment; Parkinson’s disease; RANTES; immunological disturbances; serum

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1600-0404.2007.00894.x

Affiliations: 1: Departments of Neurology 2: Biopathology-Immunology, School of Medicine, Athens National University, Aeginition Hospital, Athens, Greece

Publication date: 2007-12-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more